Pharmacokinetic Study of 48-hour Sevoflurane Inhalation Using a Disposable Delivery System (AnaConDa©) in Obese ICU Patients

NCT02042612 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

8

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Sedation with sevoflurane during 48-hr in ICU

Sponsor

University Hospital, Clermont-Ferrand